Modulation of gastrointestinal physiology through probiotic strains of Lactobacillus casei and Bifidobacterium bifidum;Modulación de la fisiología gastrointestinal mediante cepas probióticas de Lactobacillus casei y Bifidobacterium bifidum

Anales del Sistema Sanitario de Navarra

Volumn 29, Issue 3, 2006, Pages 337-347

  Barrenetxe, J ^a   Aranguren, P ^a   Grijalba, A ^b   Martinez Penuela J M ^b   Marzo, F ^a   Urdaneta, Elena ^a  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^b Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

Intestine; PEPT1; Prebiotic strains; SGLT1

Indexed keywords

ALPHA GLUCOSIDASE; AMINOPEPTIDASE; PEPTIDE TRANSPORTER 1; PROBIOTIC AGENT; SODIUM GLUCOSE COTRANSPORTER 1; SUCRASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME ACTIVITY; FUNCTIONAL FOOD; IMMUNITY; INTESTINE FUNCTION; LACTOBACILLUS CASEI; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BIFIDOBACTERIUM; GASTROINTESTINAL TRACT; LACTOBACILLUS CASEI; MICE; PROBIOTICS;

EID: 33846298495     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. WARNER, M. Marketing fortified food to those leery of drugs. 2005; The New York Times. 28th December 2005.
2. RODRÍGUEZ, A. Las despensas se transforman en farmacias. El Mundo del siglo XXI, 7 de enero de 2006.
3. EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 2005; 59: 1387-1396.
4. GUARNER F. AND MALAGELADA JR. Gut flora in health and disease. Lancet 2003; 360: 512-519.
5. SAARELA M, LÄHTEENMÄKI, L, CRITTENDEN R, SALMINEN S, MATTILA-SANDHOLM T. Gut bacteria and health foods - The European perspective. Int J Food Microbiol 2002; 78: 99-117.
6. SHANAHAN F. The host-microbe interface within the gut. Best Practice & Res Clin Gastroenterol 2002; 16: 915-931.
7. TLASKALOVÁ-HOGENOVÁ H, ŠTĚPÁNKOVÁA R, HUDCOVIC T, TǓCKOVÁ L, CUKROWSKA B, LODINOVÁ -ŽÁDNÍKOVÁ R et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters 200; 93: 97-108.
8. BENGMARJK S. Immunonutrition: Role of biosurfactants, fiber, and probiotic bacteria. Nutrition 1998; 14: 585-594.
9. PHILPOTT M, FERGUSON LR. Immunonutrition and cancer. Mut Res 2004; 551: 29-42.
10. FERGUSON LR, PHILPOTT M, KARUNASINGHE N. Dietary cancer and prevention using antimutagens. Toxicology 2004; 198: 147-159.
11. LÓPEZ-ABENTE G, POLLÁN M, ARAGONÉS N, PÉREZ B, HERNÁNDEZ V, LOPE V, SUÁREZ B. Situación del cáncer en España: incidencia. An Sist Sanit Navar 2004; 27: 165-173.
12. KWAK NS, JUKES DJ. Functional foods. Part 1: the development of a regulatory concept. Food Control 2001; 12: 99-107.
13. SALMINEN S, OUWEHAND AC, ISOLAURI E. Clinical applications of probiotic bacteria. Intern Dairy J 1998; 8: 563-572.
14. HIRAYAMA K, RAFTER J. The role of probiotic bacteria in cancer prevention. Microbes Infect 2000; 2: 681-686.
15. KOPP-HOOLIHAN, L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001; 1012: 229-241.
16. MARTEAU P, SEKSIK P, JIAN R. Probiotics and health: new facts and ideas. Curr Opin Biotechnol 2002; 13: 486-489.
17. KAUR IP, CHOPRA K, SAINI A. Probiotics: potential pharmaceutical applications. Eur J Pharmac Sci 2002; 15: 1-9.
18. WAGNER RD, BALISH E. Potential hazards of probiotic bacteria for immunodeficient patients. Bull Inst Pasteur 1998; 96: 165-170.
19. HERMAN M, MÉNARD S. Probiotic microrganisms: how they affect intestinal pathophysiology. Cellular and Molecular Life Sciences 2002; 59: 1151-1165.
20. KLEIN G, PACK A, BONAPARTE CH, REUTER G. Taxonomy and physiology of probiotic lactic acid bacteria. Int J Food Microbiol 1998; 41: 103-125.
21. RAFTER J. Probiotics and colon cancer. Best Practice & Research Clinical Gastroenterology 2003; 17: 849-859.
22. SHANAHAN F. Probiotics in inflammatory bowel disease. Gut 2001; 48: 609.
23. KIRJAVAINEN PV, EL-NEZAMI HS, SALMINEN SJ, AHOGAS JT, WRIGHT PFA. The effect of orally administred viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol 1999; 26: 131-135.
24. KITAZAWA H, UEHA S, SHIHOKO ITOH S, WATANABE H, KONNO K, KAWAI Y et al. AT oligonucleotides inducing B lymphocyte activation exist in probiotic Lactobacillus gasseri. Int J Food Microbiol 2001; 65: 149-162.
25. LEE JW, SHIN JG, KIM E, KANG H, YIM IB, KIM J et al. Immunomodulatory and antitumor effects in vivo by the cytoplasmatic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 2004 5; 41-48.
26. KITAZAWA H, INO T, KAWAI Y, ITOH T, SAITO T. A novel immunostimulating aspect of Lactobacillus gasseri: induction of "Gasserokine" as chemoattractants for macrophages. Int J Food Microbiol 2002; 77: 29-38.
27. DUBUQUOY L, JANSSON EA, DEEB S, RAKOTOBE S, KAROUI M, COLOMBEL JF. Impaired expression of peroxisome proliferactor-activated receptor gamma in ulcerative colitis. Gastroenterology 2003; 124: 1538-1542.
28. YOU HJ, OH DK, JI GE. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium BGN4. FEMS Microbiol Lett 2004; 240: 131-136.
29. IRIGOYEN A, ARANA I, CASTIELLA M, TORRE P, IBÁÑEZ FC. Microbiological, physicochemical and sensory characteristics of kefir during storage. Food Chem 2005; 90: 613-620.
30. SHIRAZY-BEECHEY SP, DAVIES AG, TEBBUT K, DYER J, ELLIS A, TAYLOR CJ et al. Preparation and properties of brush border membrane vesicles from human small intestine. Gastroenterol 1990; 98: 676-685.
31. DAHLQVIST, A. Method for assay of intestinal disaccharidases. Annal Biochem 1964; 7: 18-25.
32. ANDRIA G, CUCCHIARA S, DE VIZIA B, DE RITIS G, MASAKA G, AURICHIO S. Brush border and cytosol peptidase activities of human small intestine n normal subjects and celiac patients. Pediatr Res 1980; 14: 812-818.
33. HOPFER U, SIGRIST-NELSON K, PEROTTO J, MURER H. Intestinal sugar transport: studies with isolated plasma membranes. Ann NY Acad Sci 1975; 264: 414-427.
34. EZENDAN J, VAN LOVEREN H. Probiotics: immunomodulation and evaluation of safety and efficacy. Nutr Rev 2006; 64: 1-14.
35. MC GARR SE, RIDLON JM AND HYLEMON PB. Diet, anaerobic bacterial metabolism and colon cancer: a review of the literature. J Clin Gastroenterol 2005; 39: 98-109.
36. NEUDECK BL, LOEB JM, FAITH NG. Lactobacillus casei alters hPEPT1-mediated glycylsarcosine uptake in Caco-2 cells. J Nutr 2004; 134: 1120-1123.
37. ROLLER M, RECHKEMMER G, WATZL B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr 2004; 134: 153-156.
38. LIN DC. Probiotics as functional foods. Nutr Clin Pract 2003; 18: 497-506.
39. YASUI H, OHWZKI M. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci 1991; 74: 1187-1195.
40. COMMANE DM, SHORTT CT, SILVI S, CRESCI A, HUGHES RM, ROWLAND IR. Effects of fermentation products of pro- and prebiotics on transepithelial resistance in an invitro model of the colon. Nutr Cancer 2005; 51: 102-109.
41. +/Peptide transporter PepT1. Gastroenterology 1999; 116: 354-362.
42. ADIBI SA Regulation of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol Gastrointest Liver Physiol 2003; 285: G779-G788.
43. FERRARIS RP. Dietary and developmental regulation of intestinal sugar transport. Biochem J 2001; 360: 265-276.
44. YANG SC, CHEN JY, SHANG HF, CHENG TY, TSOU SC, CHEN JR. Effect of synbiotics on intestinal microflora and digestive enzyme activities in rats. World J Gastroenterol 2005; 11: 7413-7417.
45. DEMIRER S, AYDINTUG S, ASLIM B, KEPENECKI I, SENGUL N, EVIRGEN O et al. Effects of probiotics on radiation-induced intestinal injury in rats. Nutrition 2006; 22: 179-186.
46. DOCK DB, AGUILAR-NASCIMENTO JE, LATORRACA MQ. Probiotics enhance the recovery of gut atrophy in experimental malnutrition. Biocell 2004; 28: 143-150.
47. SMIRNOV A, PEREZ R, AMIT-ROMACH E, SKLAN D, UNI Z. Mucin dynamics and microbial populations in chicken small intestine are changed by dietary probiotic and antibiotic growth promoter supplementation. J Nutr 2005; 135: 187-192.
48. BARRENETXE J, ARANGUREN P, GRIJALBA A, MARTÍNEZ-PEÑUELA JM, MARZO F, URDANETA E. Effect of dietary quercetin and sphingomyelin on intestinal nutrient absorption and animal growth. Br J Nutr 2006; 95: 455-461.